Sareum Holdings plc (SAR.L) LSE
Currency In GBp
- General
- Statistics
- Historical Data
- Profile
- Financials
Sareum Holdings plc
Address
Langford Arch
Cambridge, CA CB22 3FX
United Kingdom of Great Britain and Northern Ireland (the)
Phone
44 1223 497 700
Website
Sector
Healthcare
Industry
Biotechnology
Employees
5
First IPO Date
October 11, 2004
Key Executives
| Name | Title | Pay | Year Born |
| Clive H. W. Birch | Secretary & Senior Independent Non-Executive Director | 27,500 | 1953 |
| Stephen Barry Parker DPhil | Executive Chairman | 130,892 | 1958 |
| Timothy John Mitchell | Founder, Chief Operating Officer & Executive Director | 159,494 | 1960 |
| John Charles Reader | Founder, Chief Scientific Officer & Executive Director | 246,595 | 1967 |
| Alexandra Harrison | Head of IR | 0 | N/A |
Description
Sareum Holdings plc operates as a specialized pharmaceutical company, primarily focused on discovering and advancing innovative therapeutic compounds for treating both cancer and autoimmune conditions. The firm develops small-molecule drugs, utilizing its proprietary Sareum Kinase Inhibitor Library as its core drug discovery platform. Its development portfolio currently features programs targeting Checkpoint Kinase 1, Aurora+FLT3 kinase, and TYK2/JAK1 kinase. Sareum has also forged strategic partnerships with the Hebei Medical University Biomedical Engineering Center and Sierra Oncology, Inc. Founded in 2003, the company is headquartered in Cambridge, United Kingdom.
